The North America Gene Synthesis Market was valued at USD 1.35 Billion in 2024 and is expected to reach USD 7.28 Billion by 2032, growing at a CAGR of 23.4% (2025-2032).

The North America Gene Synthesis Market was valued at USD 1.35 Billion in 2024 and is expected to reach USD 7.28 Billion by 2032, growing at a CAGR of 23.4% (2025-2032).

The Middle East and Africa Gene Synthesis Market was valued at USD 45.53 Million in 2021 and is expected to reach USD 166.43 Million by 2029, growing at a CAGR of 17.4% (2022-2029).

The Asia-Pacific Gene Synthesis Market was valued at USD 429.59 Million in 2021 and is expected to reach USD 2,557.01 Million by 2029, growing at a CAGR of 24.7% (2022-2029).

The Europe Gene Synthesis Market was valued at USD 467.74 Million in 2021 and is expected to reach USD 2,232.16 Million by 2029, growing at a CAGR of 21.1% (2022-2029).